Search research articles
Contact Us
Filters
Showing results (231-240 of 411) with videos related to
Page
of 42
Sort By:
British Journal of Cancer
|
May 1, 1988
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee)
D B Smith, M J Lind, S B Kaye, et al.
BMJ Case Reports
|
June 21, 2011
Keratoconus associated with congenital stationary night blindness type 1
D Q Nguyen, C Hemmerdinger, R P Hagan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC
J F Smyth, I E Smith, C Sessa, et al.
British Journal of Cancer
|
November 1, 1995
A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists
G C Howard, K Clarke, M H Elia, et al.
British Journal of Cancer
|
November 1, 1988
A pilot study of carboplatin (JM8, CBDCA) and chlorambucil in combination for advanced ovarian cancer
M Harding, R Kennedy, L Mill, et al.
The British Journal of Dermatology
|
August 27, 2005
Mucous membrane pemphigoid: management of advanced ocular disease with intravenous cyclophosphamide and amniotic membrane transplantation
P D Yesudian, S Armstrong, J I Cawood, et al.
British Journal of Cancer
|
December 1, 1991
Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee
R D Rubens, S B Kaye, M Soukop, et al.
The British Journal of Oral & Maxillofacial Surgery
|
April 1, 1997
The establishment of a xerostomia clinic: a prospective study
E A Field, L P Longman, R Bucknall, et al.
British Journal of Cancer
|
October 1, 1994
Bolus/infusional 5-fluorouracil and folinic acid for metastatic colorectal carcinoma: are suboptimal dosages being used in the UK?
D I Jodrell, L S Murray, N S Reed, et al.
Journal of the National Cancer Institute
|
April 1, 1992
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme
M A Graham, D Bissett, A Setanoians, et al.
Page
of 42
Search research articles
Search
Showing results (231-240 of 411) with videos related to
Sort By:
Page
of 42
British Journal of Cancer
|
May 1, 1988
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee)
D B Smith, M J Lind, S B Kaye, et al.
BMJ Case Reports
|
June 21, 2011
Keratoconus associated with congenital stationary night blindness type 1
D Q Nguyen, C Hemmerdinger, R P Hagan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC
J F Smyth, I E Smith, C Sessa, et al.
British Journal of Cancer
|
November 1, 1995
A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists
G C Howard, K Clarke, M H Elia, et al.
British Journal of Cancer
|
November 1, 1988
A pilot study of carboplatin (JM8, CBDCA) and chlorambucil in combination for advanced ovarian cancer
M Harding, R Kennedy, L Mill, et al.
The British Journal of Dermatology
|
August 27, 2005
Mucous membrane pemphigoid: management of advanced ocular disease with intravenous cyclophosphamide and amniotic membrane transplantation
P D Yesudian, S Armstrong, J I Cawood, et al.
British Journal of Cancer
|
December 1, 1991
Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee
R D Rubens, S B Kaye, M Soukop, et al.
The British Journal of Oral & Maxillofacial Surgery
|
April 1, 1997
The establishment of a xerostomia clinic: a prospective study
E A Field, L P Longman, R Bucknall, et al.
British Journal of Cancer
|
October 1, 1994
Bolus/infusional 5-fluorouracil and folinic acid for metastatic colorectal carcinoma: are suboptimal dosages being used in the UK?
D I Jodrell, L S Murray, N S Reed, et al.
Journal of the National Cancer Institute
|
April 1, 1992
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme
M A Graham, D Bissett, A Setanoians, et al.
Page
of 42